Slate Path Capital LP - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 36 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Slate Path Capital LP ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,105,683
-33.9%
7,157,6010.0%0.15%
-42.3%
Q4 2022$4,696,818
-23.7%
7,157,6010.0%0.25%
-36.8%
Q3 2022$6,156,000
+56.7%
7,157,6010.0%0.40%
+63.3%
Q2 2022$3,928,000
-50.6%
7,157,6010.0%0.24%
-39.8%
Q1 2022$7,945,000
-35.5%
7,157,6010.0%0.41%
-36.9%
Q4 2021$12,311,000
-44.0%
7,157,6010.0%0.64%
-35.7%
Q3 2021$21,974,000
-21.3%
7,157,6010.0%1.00%
-35.7%
Q2 2021$27,915,000
+61.5%
7,157,601
+15.5%
1.56%
+39.1%
Q1 2021$17,287,000
-8.8%
6,196,0630.0%1.12%
+9.3%
Q4 2020$18,960,000
-49.7%
6,196,0630.0%1.03%
-52.1%
Q3 2020$37,672,000
+432.9%
6,196,063
+418.0%
2.14%
+414.1%
Q2 2020$7,069,000
+123.0%
1,196,0630.0%0.42%
+71.6%
Q1 2020$3,170,000
-70.3%
1,196,063
+35.9%
0.24%
-65.6%
Q3 2019$10,666,000
+30.5%
880,000
+23.2%
0.71%
+92.4%
Q2 2019$8,176,000714,0180.37%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Slate Path Capital LP 7,157,601$3,105,6830.15%
Artal Group S.A. 2,779,122$1,2060.07%
MFN Partners Management, LP 3,389,215$1,470,5800.07%
Intrinsic Value Partners, LLC 43,105$18,7030.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,000$49,8990.00%
Penobscot Investment Management Company, Inc. 10,000$4,3390.00%
COLONY GROUP LLC 102,884$440.00%
CAPTRUST FINANCIAL ADVISORS 292,645$126,9790.00%
GEODE CAPITAL MANAGEMENT, LLC 592,237$256,9710.00%
STATE STREET CORP 115,414$50,0780.00%
View complete list of CYCLERION THERAPEUTICS INC shareholders